Frequent Interpersonal Stress and Inflammatory Reactivity Predict Depressive-Symptom Increases: Two Tests of the Social-Signal-Transduction Theory of Depression

2021 ◽  
pp. 095679762110312
Author(s):  
Annelise A. Madison ◽  
Rebecca Andridge ◽  
M. Rosie Shrout ◽  
Megan E. Renna ◽  
Jeanette M. Bennett ◽  
...  

The social-signal-transduction theory of depression asserts that people who experience ongoing interpersonal stressors and mount a greater inflammatory response to social stress are at higher risk for depression. The current study tested this theory in two adult samples. In Study 1, physically healthy adults ( N = 76) who reported more frequent interpersonal tension had heightened depressive symptoms at Visit 2, but only if they had greater inflammatory reactivity to a marital conflict at Visit 1. Similarly, in Study 2, depressive symptoms increased among lonelier and less socially supported breast-cancer survivors ( N = 79). This effect was most pronounced among participants with higher inflammatory reactivity to a social-evaluative stressor at Visit 1. In both studies, noninterpersonal stress did not interact with inflammatory reactivity to predict later depressive symptoms.

2011 ◽  
Vol 29 (26) ◽  
pp. 3517-3522 ◽  
Author(s):  
Julienne E. Bower ◽  
Patricia A. Ganz ◽  
Michael R. Irwin ◽  
Lorna Kwan ◽  
Elizabeth C. Breen ◽  
...  

Purpose Fatigue, depression, and sleep disturbance are common adverse effects of cancer treatment and frequently co-occur. However, the possibility that inflammatory processes may underlie this constellation of symptoms has not been examined. Patients and Methods Women (N = 103) who had recently finished primary treatment (ie, surgery, radiation, chemotherapy) for early-stage breast cancer completed self-report scales and provided blood samples for determination of plasma levels of inflammatory markers: soluble tumor necrosis factor (TNF) receptor II (sTNF-RII), interleukin-1 receptor antagonist, and C-reactive protein. Results Symptoms were elevated at the end of treatment; greater than 60% of participants reported clinically significant problems with fatigue and sleep, and 25% reported elevated depressive symptoms. Women treated with chemotherapy endorsed higher levels of all symptoms and also had higher plasma levels of sTNF-RII than women who did not receive chemotherapy (all P < .05). Fatigue was positively associated with sTNF-RII, particularly in the chemotherapy-treated group (P < .05). Depressive symptoms and sleep problems were correlated with fatigue but not with inflammatory markers. Conclusion This study confirms high rates of behavioral symptoms in breast cancer survivors, particularly those treated with chemotherapy, and indicates a role for TNF-α signaling as a contributor to postchemotherapy fatigue. Results also suggest that fatigue, sleep disturbance, and depression may stem from distinct biologic processes in post-treatment survivors, with inflammatory signaling contributing relatively specifically to fatigue.


2010 ◽  
Vol 123 (2) ◽  
pp. 477-485 ◽  
Author(s):  
Jessica R. Gorman ◽  
Vanessa L. Malcarne ◽  
Scott C. Roesch ◽  
Lisa Madlensky ◽  
John P. Pierce

2010 ◽  
Vol 31 (1) ◽  
pp. 36-37 ◽  
Author(s):  
Sherylyn Briller

Abel, Emily and Subramanian Saskia. After the Cure: Untold Stories of Breast Cancer Survivors (2008)Mary HollensDagg Innis, Anne. The Social Behavior of Older Animals (2009) Georgia Richardson-Melody


Author(s):  
Reina Haque ◽  
Jin Wen Hsu ◽  
Chantal Avila ◽  
Richard Olmstead ◽  
Judith E. Carroll ◽  
...  

2014 ◽  
Vol 33 (3) ◽  
pp. 242-248 ◽  
Author(s):  
Alan E. C. Holden ◽  
Amelie G. Ramirez ◽  
Kipling Gallion

Sign in / Sign up

Export Citation Format

Share Document